October 15, 2008
Crowne Plaza Hotel - Palo Alto
4290 El Camino Real
Palo Alto, CA 94306

› Photos & Highlights
› Agenda
› Speaker Bios
› Sponsors
› Refund and Cancellation Policy

PHOTOS
 
The conference, Medical Technology Executive Forum Key Commercialization Issues Impacting the Medical Technology Industry, was held in Palo Alto, California and provided attendees an executive level overview of several key areas in the commercialization process.
 
David Sayen, Regional Administrator of the Centers for Medicare and Medicaid Services, highlighted the key reimbursement challenges manufacturers currently face in attempting to secure both private and public reimbursement. Dr. Dan Schultz, Director of the Center of Devices and Radiological Health (CDRH) provided the keynote presentation at the conference.
 
 
HIGHLIGHTS

The Medical Device Manufacturers Association held a successful conference on October 15, 2008 designed specifically for executives of medical technology companies. The conference, Medical Technology Executive Forum Key Commercialization Issues Impacting the Medical Technology Industry, was held in Palo Alto, California and provided attendees an executive level overview of several key areas in the commercialization process.

The conference commenced with a session focused on developing funding for medical technologies. Presenters Casey McGlynn, Partner and Chairman Life Sciences Group, Wilson Sonsini Goodrich & Rosati, and Mark Wan, Partner, Three Arch Partners provided their perspective on the state of the industry as well as guidance on how to appropriate secure funding for medical technologies. Sabing Lee, a Partner at the law firm of Knobbe Martens gave an overview of the state of intellectual property and the impact of recent patent law decisions.

Dr. Dan Schultz, Director of the Center of Devices and Radiological Health (CDRH) provided the keynote presentation at the conference. In his remarks, Dr. Schultz noted some of the key changes device manufactures will face in light of recent legislative changes. Following Dr. Schultz’s remarks, David Sayen, Regional Administrator of the Centers for Medicare and Medicaid Services, Sue Rowinski, Principal at the Sue Rowinski Group LLC, and Thomas Novelli, Director of Federal Affairs at MDMA, highlighted the key reimbursement challenges manufacturers currently face in attempting to secure both private and public reimbursement.

Rick Davies, Managing Partner at Vector Resources and Chris Davies, Partner at Vector Resources, presented on the critical steps necessary to successfully develop a commercialization strategy for new medical technologies. Karen Gibbs, a Partner at the law firm of Crowell & Moring shared insight into challenges manufacturers likely will face competing in the marketplace as well as distributing their products.

The conference concluded with a presentation by Daniel Meron, a Partner at the law firm of Latham and Watkins. Meron, who formerly was General Counsel at the Department of Health and Human Services, described the prevailing fraud and abuse issues in the medical technology arena while sharing his insight into what the impact of current and future fraud and abuse laws could have on medical technology companies as they market their products.

Agenda

Wednesday, October 15th

8:00 - 8:45 am

Registration and Breakfast

   

8:45 - 9:15 am

Welcome and Opening Remarks

Mark Leahey, Executive Director, MDMA

   

9:15 - 10:00 am

Attracting Funding and Deal Design

J.Casey McGlynn, Partner and Chairman Life Sciences Group, Wilson Sonsini Goodrich & Rosati

Mark Wan, Partner, Three Arch Partners
   

10:00 - 10:30 am

Intellectual Property - Protecting and Licensing your Technology in the Changing Environment

Sabing Lee , Partner, Knobbe Martens
   

10:30 - 10:50 am

Networking Break

   

10:50 - 12:00 pm

CDRH Update and Other Key FDA Issues

John Manthei, Partner, Latham & Watkins

Daniel G. Schultz MD, Director, Center for Devices and Radiological Health

   

12:00 - 1:00 pm

Networking Lunch
   

1:00 - 2:00 pm

Reimbursement Opportunities and Challenges in 2008 and Beyond

David Sayen, Regional Administrator, Centers for Medicare and Medicaid Services

Sue Rowinski, Principal, Sue Rowinski Group LLC

Thomas C. Novelli, Director of Federal Affairs, MDMA
   

2:00 - 3:00 pm

Developing an Appropriate Commercialization Strategy
Rick Davies, Managing Partner, Vector Resources
Chris Davies, Partner, Vector Resources

  • Preparing to Launch
    Addressing the 3 commercialization imperatives
  • Selecting a Successful Strategy
    Not all commercialization strategies fit all products & business objectives
   

3:00 - 3:15 pm

Networking Break

   

3:15 - 3:45 pm

Strategic Management of Distribution and Competitive Challenges
Karen Gibbs, Partner, Crowell & Moring

  • Distribution Challenges in the US
  • Options for Global Distribution
  • Stopping Competitor Misconduct
  • Recognizing the Importance of Compliance
   

3:45 - 4:15 pm

Fraud and Abuse Update
Daniel Meron, Partner, Latham & Watkins

   

Sponsors
 
     
 
 
     
     
Supporting Organizations
     
     

 

 
   
 
     
     
 
Media Sponsors
 
   
   
   

 

Cancellation & Refund Policy

If you cancel in writing on or before September 25, 2008, you will be refunded your registration fee after an administrative charge of $75. Cancellations not received by this date will not be eligible for a refund. No shows will not be refunded. Balances are due prior to the start of the event.

Sessions and speakers are subject to change without notice. MDMA reserves the right to cancel or reschedule any program, whereupon full registration fees will be refunded or applied to the rescheduled program in accordance with the registrant's preference. In the event of cancelled programs, MDMA assumes no responsibility for transportation, hotel, or other expenses incurred by registrants.

Questions?

Please contact Erin Jones MDMA's Director of Membership & Programs at (202) 354-7172.